Bresles, France

Andre Champagnac


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 1 
 
Laboratoires Sauba S.a.
 patent
silverMedal1 out of 38 
 
Université D'orleans
 patents
bronzeMedal1 out of 832,912 
Other
 patents
where one patent can have more than one assignee

Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andre Champagnac

Introduction

Andre Champagnac is a notable inventor based in Bresles, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic drugs. His innovative approach has led to the creation of a unique compound that showcases his expertise in medicinal chemistry.

Latest Patents

Champagnac holds a patent for an analgesic drug containing a derivative of benzylpiperazine. The drug features an active substance consisting of 1-(3'-benzofuryl)-4-benzylpiperazine. To prepare this compound, a reaction is conducted with reflux between 3-coumaranone and N-benzylpiperazine in the presence of acetic acid and an aromatic solvent. This innovative formulation highlights his ability to create effective pain relief solutions.

Career Highlights

Throughout his career, Andre Champagnac has worked with various organizations, including Laboratoires Sauba S.A. His work has been instrumental in advancing pharmaceutical research and development. His dedication to innovation has positioned him as a key figure in the industry.

Collaborations

Champagnac has collaborated with notable individuals such as Andre Buzas and Jean-Marie Melon. These partnerships have allowed him to enhance his research and contribute to the development of new pharmaceutical solutions.

Conclusion

Andre Champagnac's contributions to the field of pharmaceuticals, particularly through his patented analgesic drug, demonstrate his innovative spirit and commitment to improving pain management. His work continues to influence the industry and inspire future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…